title: Vemurafenib-induced granuloma annulare.
authors.affiliation: Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
authors.forename: Sophia Boyoung
authors.initials: SB
authors.lastname: Lee
authors.affiliation: Division of Dermatooncology, Department of Dermatology, University Medical Center Tuebingen, Tuebingen, Germany.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Weide
authors.affiliation: Division of General Dermatology, Medical University of Graz, Graz, Austria.
authors.forename: Selma
authors.initials: S
authors.lastname: Ugurel
authors.affiliation: Department of Dermatology, University of Goettingen, Goettingen, Germany.|Committee for Cutaneous Side Effects of the DeCOG (ADO).
authors.forename: Rotraut
authors.initials: R
authors.lastname: Mössner
authors.affiliation: Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Enk
authors.affiliation: Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.|Committee for Cutaneous Side Effects of the DeCOG (ADO).
authors.forename: Jessica Cecile
authors.initials: JC
authors.lastname: Hassel
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology*; D005260:Female; D016460:Granuloma Annulare / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib